Global Implantable VNS Devices Market Research Report - Segmented by Application (Depression, Epilepsy, Migraine); By End User (Hospitals, Ambulatory Surgical Centers, Others), and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15005
Format:
Region: Global
Chapter 1. Implantable VNS Devices Market– Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Implantable VNS Devices Market– Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Implantable VNS Devices Market– Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Implantable VNS Devices Market- Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Implantable VNS Devices Market- Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Implantable VNS Devices Market- By Application
6.1 Depression
6.2 Epilepsy
6.3 Migraine
6.4 Others
Chapter 7. Implantable VNS Devices Market- - By End User
7.1 Hospitals
7.2 Ambulatory Surgical Centers
7.3 Others
Chapter 8. Implantable VNS Devices Market– By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Latin America
8.5 The Middle East
8.6 Africa
Chapter 9. Implantable VNS Devices Market – Key Players
9.1 LivaNova Plc.
9.2 EnteroMedics Inc.
9.3 Beijing Pharmaceutical Group Co., Ltd.
9.4 BioControl Medical (B.C.M) Ltd.
9.5 electroCore LLC
9.6 Cyberonics
9.7 Neurospace
9.8 MicroTransponder, Inc.
9.9 Medtronic
9.10 Cerebral Rx
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Implantable VNS Devices Market was estimated to be worth $312.8 million in 2022, and it is projected to reach $ 715.68 million by the end of 2030, with a CAGR of 10.9 % during the forecast period (2023 - 2030).
The increase in severe and otherwise untreatable neurological diseases is poised to drive market growth for Implantable VNS Devices.
The Implantable VNS Devices Market's growth is being challenged by the high costs the implantable devices, surgery, and the health risks involved.
LivaNova Plc., EnteroMedics Inc., Beijing Pharmaceutical Group Co., Ltd., BioControl Medical (B.C.M) Ltd., and electroCore LLC are some of the major players in the Implantable VNS Devices market.
The Implantable VNS Devices Market by application is segmented into Depression, Epilepsy, Migraine, and Others.
